Incorrect username and/or password, please try again or click to reset.

Class 4 Medicines Defect Information: Emerade 150, 300 and 500 microgram solution for injection in pre-filled syringe (MDR 55-06/18)

2019-07-11 11:00:24 (2 month(s) ago)

Summary

Pharmaswiss ńĆeska republika s.r.o. (an affiliate of Bausch & Lomb UK Limited) has informed us of a risk of Emerade product failing to deliver a dose of adrenaline from the syringe due to blockage of the needle.

Read full MHRA article

Respond to this alert